PURCHASE AGREEMENT by and between ONCOBIOLOGICS, Inc. and GMS TENSHI HOLDINGS PTE. LIMITED Dated May 11, 2018Purchase Agreement • May 15th, 2018 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York
This PURCHASE AGREEMENT (this “Agreement”), dated as of May 11, 2018, is entered into by and between Oncobiologics, Inc., a Delaware corporation (the “Company”), and GMS Tenshi Holdings Pte. Limited, a Singapore private limited company (“Investor”).
AMENDMENT TO INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 15th, 2018 • Oncobiologics, Inc. • Biological products, (no disgnostic substances)
This AMENDMENT, dated as of May 11, 2018 (this “Amendment”), to the Investor Rights Agreement, dated as of September 11, 2017 (as it may be amended from time to time, the “Investor Rights Agreement”), is entered into between Oncobiologics, Inc., a Delaware corporation (the “Company”), and GMS Tenshi Holdings Pte. Limited, a Singapore private limited company (the “Investor” and, collectively with the Company, the “Parties”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Investor Rights Agreement.
